Jamjoom Pharmaceuticals Factory Co (SAU:4015) Other Current Liabilities: ﷼0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4015 Jamjoom Pharmaceuticals Factory Co SAU:4015
98 GF Score
Price ﷼142.00
GF Value ﷼178.77
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jamjoom Pharmaceuticals Factory Co Other Current Liabilities?

Jamjoom Pharmaceuticals Factory Co SAU:4015 +0.93% 98 Other Current Liabilities is ﷼0 Mil as of Jun. 2026. GuruFocus rates SAU:4015 with a GF Score™ of 98/100 and a GF Value™ of ﷼178.77 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Jamjoom Pharmaceuticals Factory Co's other current liabilities for the quarter that ended in Jun. 2026 was ﷼0 Mil.

Jamjoom Pharmaceuticals Factory Co's quarterly other current liabilities declined from Dec. 2025 (﷼144 Mil) to Mar. 2026 (﷼0 Mil) but then from Mar. 2026 (﷼0 Mil) to Jun. 2026 (﷼0 Mil).

Jamjoom Pharmaceuticals Factory Co's annual other current liabilities increased from Dec. 2023 (﷼84 Mil) to Dec. 2024 (﷼129 Mil) and increased from Dec. 2024 (﷼129 Mil) to Dec. 2025 (﷼144 Mil).

Jamjoom Pharmaceuticals Factory Co Other Current Liabilities Related Terms

Jamjoom Pharmaceuticals Factory Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jamjoom Pharmaceuticals Factory Co Other Current Liabilities Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 70.19 64.24 84.06 129.44 144.04

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 144.04 0.00 0.00
SAU:4015
98GF Score
Jamjoom Pharmaceuticals Factory Co SAU:4015
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jamjoom Pharmaceuticals Factory Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ﷼0 Mil mean?
Jamjoom Pharmaceuticals Factory Co (SAU:4015) has a Other Current Liabilities of ﷼0 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Jamjoom Pharmaceuticals Factory Co.
Is Jamjoom Pharmaceuticals Factory Co's Other Current Liabilities too high?
Jamjoom Pharmaceuticals Factory Co's current Other Current Liabilities is ﷼0 Mil. Overall, Jamjoom Pharmaceuticals Factory Co has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jamjoom Pharmaceuticals Factory Co's Other Current Liabilities compare to ZTS and UTHR?
Jamjoom Pharmaceuticals Factory Co's Other Current Liabilities of ﷼0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Jamjoom Pharmaceuticals Factory Co. Jamjoom Pharmaceuticals Factory Co's current Other Current Liabilities is ﷼0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jamjoom Pharmaceuticals Factory Co stock overvalued right now?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co (SAU:4015) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼178.77, compared to a current price of ﷼142.00 — trading 20.6% below its estimated fair value. The current Other Current Liabilities is ﷼0 Mil. Jamjoom Pharmaceuticals Factory Co's overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Jamjoom Pharmaceuticals Factory Co (SAU:4015), the current Other Current Liabilities is ﷼0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?

Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued. The current stock price of ﷼142.00 is trading 20.6% below its estimated GF Value™ of ﷼178.77. GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.

Key valuation signals for SAU:4015:

  • Other Current Liabilities: ﷼0 Mil
  • GF Value™: ﷼178.77 vs. price of ﷼142.00 (20.6% below fair value)
  • GF Score™: 98/100 with 1 warning sign

No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jamjoom Pharmaceuticals Factory Co Business Description

Address Corniche Road, P.O. Box No. 6267, 1234 Al Hamra District, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
98GF Score

Get the complete analysis for SAU:4015

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼142.00
Price
﷼178.77
GF Value